Gene expression profiles in paraffin-embedded core biopsy tissue predict response to chemotherapy in women with locally advanced breast cancer.
about
Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trialAmerican Society for Clinical Oncology 40th annual meeting, New Orleans, LA, 5-8 June 2004: breast cancer highlightsGenomic profiling in luminal breast cancerHormonal Modulation of Breast Cancer Gene Expression: Implications for Intrinsic Subtyping in Premenopausal WomenPhase II trial of tipifarnib plus neoadjuvant doxorubicin-cyclophosphamide in patients with clinical stage IIB-IIIC breast cancerPSMB7 is associated with anthracycline resistance and is a prognostic biomarker in breast cancerDiscovery of IL-18 as a novel secreted protein contributing to doxorubicin resistance by comparative secretome analysis of MCF-7 and MCF-7/DoxcDNA hybrid capture improves transcriptome analysis on low-input and archived samplesWhole transcriptome RNA-Seq analysis of breast cancer recurrence risk using formalin-fixed paraffin-embedded tumor tissueDiagnosis of pathological complete response to neoadjuvant chemotherapy in breast cancer by minimal invasive biopsy techniques.Genomancy: predicting tumour response to cancer therapy based on the oracle of genetics.Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013Unliganded progesterone receptors attenuate taxane-induced breast cancer cell death by modulating the spindle assembly checkpointIntegrated analysis of DNA methylation, immunohistochemistry and mRNA expression, data identifies a methylation expression index (MEI) robustly associated with survival of ER-positive breast cancer patients.Use of Gene Expression Profiling and Chemotherapy in Early-Stage Breast Cancer: A Study of Linked Electronic Medical Records, Cancer Registry Data, and Genomic Data Across Two Health Care Systems.A systems approach to clinical oncology: focus on breast cancer.A new molecular breast cancer subclass defined from a large scale real-time quantitative RT-PCR studyPrediction of the outcome of preoperative chemotherapy in breast cancer using DNA probes that provide information on both complete and incomplete responsesPredictors of tumor progression during neoadjuvant chemotherapy in breast cancer.Relationship between IHC4 score and response to neo-adjuvant chemotherapy in estrogen receptor-positive breast cancer.Quantitative expression profiling in formalin-fixed paraffin-embedded samples by affymetrix microarrays.Inhibition of RelB by 1,25-dihydroxyvitamin D3 promotes sensitivity of breast cancer cells to radiation.A population-based study of tumor gene expression and risk of breast cancer death among lymph node-negative patients.Prospective transGEICAM study of the impact of the 21-gene Recurrence Score assay and traditional clinicopathological factors on adjuvant clinical decision making in women with estrogen receptor-positive (ER+) node-negative breast cancer.Evaluation of a 30-gene paclitaxel, fluorouracil, doxorubicin, and cyclophosphamide chemotherapy response predictor in a multicenter randomized trial in breast cancer.Elevated thymidine kinase 1 in serum following neoadjuvant chemotherapy predicts poor outcome for patients with locally advanced breast cancerMolecular profiling contributes more than routine histology and immonohistochemistry to breast cancer diagnosticsNeutrophil gelatinase-associated lipocalin (NGAL) predicts response to neoadjuvant chemotherapy and clinical outcome in primary human breast cancer.PD-L1 Expression Correlates with Tumor-Infiltrating Lymphocytes and Response to Neoadjuvant Chemotherapy in Breast Cancer.Pathological non-response to chemotherapy in a neoadjuvant setting of breast cancer: an inter-institutional studyEstrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer.Physician survey of the effect of the 21-gene recurrence score assay results on treatment recommendations for patients with lymph node-positive, estrogen receptor-positive breast cancer.The SmgGDS splice variant SmgGDS-558 is a key promoter of tumor growth and RhoA signaling in breast cancer.Local recurrence rates are low in high-risk neoadjuvant breast cancer in the I-SPY 1 Trial (CALGB 150007/150012; ACRIN 6657)Markers for the identification of late breast cancer recurrence.Prediction of individual response to anticancer therapy: historical and future perspectivesProspective validation of immunological infiltrate for prediction of response to neoadjuvant chemotherapy in HER2-negative breast cancer--a substudy of the neoadjuvant GeparQuinto trial.Magnetic resonance metabolic profiling of breast cancer tissue obtained with core needle biopsy for predicting pathologic response to neoadjuvant chemotherapyEstrogen receptor-negative breast ductal carcinoma: clinicopathological features and MIB-1 (Ki-67) proliferative index associationRobust gene expression signature from formalin-fixed paraffin-embedded samples predicts prognosis of non-small-cell lung cancer patients
P2860
Q24597456-812A8AAB-AE4C-4B89-B525-7ADA84B8A0C0Q24796210-D378C654-41EA-4A94-B573-01F358B222C9Q26862681-E7C70B88-808F-4098-A1FA-57A81CC207C8Q28077637-911CC979-7286-4758-BE25-D38F83287363Q28240692-29017D5B-C5B4-4081-BDCC-ECFC4D476067Q28267716-008CEBC6-61BB-4A93-9B2C-9100CCC4BDB3Q28477021-EC1D3F1E-8AEA-46CA-A4DB-DA5DB37421B7Q28656404-CC14EB4A-E55B-40BD-97AC-2BCD551E2A0EQ28727086-DCADC955-8E81-459C-87B7-C81609594915Q30315973-1C5BEB67-07F6-4FCF-B0BA-98441EAD4C19Q30440216-7D7ED106-989B-4F70-8B59-C6792FCFC67AQ30543788-A34B32FC-E8DC-4FE7-82E4-31AAD5A411ABQ30560953-9975B4FC-3FE2-4E08-A040-DD0A2357807AQ30910707-40E5B780-9465-4953-A006-0FDC772AD37BQ31101528-6817117F-DFE7-46D2-A7FF-17FEC7CB35C3Q33238889-E85A88CB-59D1-4FA4-A126-3135E6CD8442Q33276929-642ADAFD-1573-4D63-9E7C-627C1023D3F0Q33325635-FCD60C9B-E878-4F95-AC50-21E75FF9AF4DQ33813431-AAD21294-200E-4262-BA85-1A804640E91EQ33843830-FEF27DEA-9953-43D7-BAE3-A5E127C041DAQ33947037-E221608C-05C4-4ED3-8C0A-91EBDB0FF26CQ33976185-B26C89E6-ABE6-4533-880D-37E1C3F6162FQ33996270-63350E9F-754B-445C-952B-EA3324ED9A0DQ34190743-70E90386-B8FE-453E-A3B8-49558A1C207BQ34275072-FA30F830-F5CF-4E12-BC4D-A263E4951A81Q34299177-E0D40877-928F-4B6E-B69D-D52D9E8BD02DQ34423475-28FA695F-D07D-4FDA-B649-31BD202B5B58Q34440998-3195923F-0A58-483B-AFC5-B9D211BDAF03Q34454922-37A3A37C-EC59-4432-B065-2A92A059078AQ34567461-EB1CA81A-D14A-45ED-AE65-59BBD7080008Q34601123-77F0FF02-123D-4EF0-9ABB-E05A0410AAA1Q34638067-903CA110-8B9D-49E0-ACE7-619BF59311F9Q34845829-5EE3C3B3-A3A3-416D-97A0-98D5A775B71BQ35000874-F3E0E241-09C2-415B-B89A-0ACA0FE58F44Q35018949-34D45617-948B-44E3-B5D8-E3E3F97D70DFQ35024682-4048F0AA-49CD-4ABA-A348-BD86B6BA2EB8Q35060987-ADA817B5-FD20-43C0-9A83-B60012119D69Q35075617-F4D5763F-1C5E-4FA1-983B-432A32555769Q35106790-27471756-10E8-4B8B-94EC-90D2A8C30686Q35196367-586EAD0A-5430-4481-A899-5EF4ABE1373A
P2860
Gene expression profiles in paraffin-embedded core biopsy tissue predict response to chemotherapy in women with locally advanced breast cancer.
description
2005 nî lūn-bûn
@nan
2005 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
name
Gene expression profiles in pa ...... ocally advanced breast cancer.
@ast
Gene expression profiles in pa ...... ocally advanced breast cancer.
@en
type
label
Gene expression profiles in pa ...... ocally advanced breast cancer.
@ast
Gene expression profiles in pa ...... ocally advanced breast cancer.
@en
prefLabel
Gene expression profiles in pa ...... ocally advanced breast cancer.
@ast
Gene expression profiles in pa ...... ocally advanced breast cancer.
@en
P2093
P50
P356
P1476
Gene expression profiles in pa ...... ocally advanced breast cancer.
@en
P2093
Drew Watson
Gabriel N Hortobagyi
Jaime Rodriguez
Jeffrey S Ross
Joffre Baker
Lajos Pusztai
Marialuisa Carcangiu
Maureen Cronin
P304
P356
10.1200/JCO.2005.02.0818
P407
P577
2005-09-06T00:00:00Z